Skip to main contentSkip to main content
Updating results

Patient

  • Updated

Merck’s molnupiravir is not authorized for children because it might interfere with bone growth. It also isn't recommended for pregnant women …

  • Updated

THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19. The U.S. Food and Drug Administration on Thursday approved the emergency use of the molnupiravir pill from Merck for the treatment of mild-to-moderate COVID-19 in people who have just tested positive.

  • Updated

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News